Sales rise 8% to EUR 354 million EBITDA of EUR 46 million around 18% higher than the previous year; EBITDA margin at around 13% Groundbreaking ceremony for new CreAMINO®1 production plant in Trostberg in March 2018 Forecast for 2018: strong mid-single-digit percentage growth in revenue and significant EBITDA growth in the upper single-digit percentage range
News Übersicht
All Categories
Today, our majority shareholders LIVIA Corporate Development SE, HDI Vier CE GmbH and Edelweiß Holding GmbH notified us that the intended placement of up to 18,000,000 shares was canceled.
Today, our majority shareholders LIVIA Corporate Development SE, HDI Vier CE GmbH and Edelweiß Holding GmbH notified us of their intention to place up to 18,000,000 shares, corresponding to approximately 17.7% of AlzChem Group AG 's share capital, with institutional investors via an accelerated bookbuilding.
Good demand and long-term customer orders allow expansion of nitrile production Investment in the amount of EUR 7.2 million Expansion of the product range to include highly corrosive nitriles
9-month sales of EUR 272.7 million up 8.9% on the previous year (EUR 250.5 million) Adjusted EBITDA1 of EUR 40.5 million approximately 13% up on the previous year (EUR 35.9 million); adjusted EBITDA margin at 14.9% Production capacity for the feed additive CreAMINO® to triple2
Investment in the amount of EUR 50 million in the expansion of the production plant for the feed additive CreAMINO®1 at the Trostberg site Production capacities to triple
AlzChem AG incorporated into the listed company AlzChem Group AG (formerly Softmatic AG) As of today, AlzChem shares can be traded on the Prime Standard of the Frankfurt Stock Exchange Half-year 2017 figures for sales and EBITDA above the previous year’s level
Im Rahmen der von der Hauptversammlung vom 4. August 2017 beschlossenen Kapitalerhöhung gegen Bareinlagen wurden bis zum Ablauf der Bezugsfrist 1.130.016 Aktien gegen Zahlung des Bezugspreises von EUR 2,30 je neuer Aktie bezogen.